Home > About Fogarty > Advisory Board > Report of the Director Archives > 09-10-2002
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Public Health Service
National Institutes of Health
John E. Fogarty International Center
for Advanced Study in the Health Sciences
Minutes of the Advisory Board
Fifty-second Meeting
Table of Contents
- DHHS, NIH, and FIC Personnel Announcements
- FIC Budget
- FIC 35th Anniversary Events
- FIC Programs and Initiatives
- Multilateral Initiative on Malaria (MIM)
- Regional Activities
- Activities of FIC Staff Members
I. DHHS, NIH, and FIC Personnel Announcements
Dr. Francisco Ayala, former member of the FIC Advisory Board, was awarded the 2001 Medal of Science by the President at a White House ceremony on June 13. Dr. Ayala was recognized for his contributions to evolution theory by pioneering the use of molecular biology methods in the investigation of evolutionary processes. Also honored was former NIH Director Harold Varmus, who was acknowledged for his effective stewardship of NIH.
Dr. Gro Harlem Brundtland, Director General of the World Health Organization (WHO), has announced that she will leave WHO at the end of her current term in July 2003. Elections for a new Director General will take place in May 2003 at the World Health Assembly.
Dr. Richard Carmona was confirmed by the U.S. Senate on July 23 to become the U.S. Surgeon General. Dr. Carmona comes to this position from posts as a Clinical Professor of Public Health, Surgery and Family and Community Medicine at the University of Arizona, medical director of the Arizona Department of Public Safety Air Rescue Unit, department surgeon and SWAT training officer at the Pima County Sheriff's Department, and attending surgeon at the U.A. Campus Student Health Center. He replaces Dr. David Satcher, whose term ended in February.
Mr. Scott Evertz, who has been serving as director of the White House Office of AIDS Policy, moved to HHS in July to become special assistant to the Secretary on international HIV/AIDS policy. In this capacity, his goal will be to assist in further developing and implementing the department's overall strategy to fight HIV/AIDS around the world, including the Global Fund to Fight HIV, Tuberculosis and Malaria.
Dr. Kathie Olsen has been confirmed by the Senate to the post of associate director at the White House Office of Science and Technology Policy (OSTP). Dr. Olsen, who has been serving as chief scientist at the National Aeronautics and Space Administration, will manage the OSTP science portfolio, including issues relating to the environment, life and physical sciences, engineering and social, behavioral and education sciences.
Dr. Julie Gerberding was named by Secretary Thompson as the new director of the Centers for Disease Control and Prevention (CDC) and administrator for the Agency for Toxic Substances and Disease Registry. She is an infectious disease expert and has been leading CDC's efforts to prepare for and counter terrorism. Dr. Gerberding previously served as the agency's acting director for science and was one of four members of the management team who had been running the agency since Dr. Jeffrey Koplan resigned in March.
Dr. John Howard has been selected as director of CDC's National Institute for Occupational Safety and Health. Dr. Howard has been chief of California's Department of Industrial Relations Division of Occupational Safety and Health since September 1991.
Dr. Jack Whitescarver was named permanent director of the NIH Office of AIDS Research (OAR) on June 2. Dr. Whitescarver served as deputy director of OAR from the time of its establishment in 1988 and has been serving as acting director since October 2000.
Dr. Donna Dean has been named deputy director of NIH's new National Institute for Biomedical Imaging and Bioengineering (NIBIB). This appointment will become effective at the end of September. Dr. Dean has served as Acting Director of the Institute from the time of its establishment in December 2000 and helped guide the Institute's formation and development.
Dr. Thomas Gallagher, formerly HHS principal deputy assistant secretary for budget, technology and finance, has been appointed as director of the NIH Office of Community Liaison. In this capacity, he is responsible for ensuring local residents are represented on a wide range of NIH activities and plans, including traffic mitigation and environmental management.
Ms. Sharon Nieberding, who served as FIC Personnel Officer for more than 20 years, retired from the Federal Government in June.
Back to top ^
II. FIC Budget
Status of FY 2003 Appropriation
Senate - On July 18, the Senate full Appropriations Committee marked up the Labor, HHS, Education Appropriations bill. The Committee added $25 million to the FY 2003 President's budget request for the NIH for a total level of $27,192,926,000. For the FIC, the Committee provided $60,880,000. This represents a reduction of $2.5 million or 40 percent below the increase proposed in the President's budget request for FY 2003. The Committee report did not include an explanation for the reduction.
The Committee report also included the following:
- Maintained NCI, NICHD, NCMHD, NLM and the Buildings and Facilities at the President's budget level.
- Reduced NIAID by $263 million and NIGMS by 1.4 million below the President's budget level.
- Increased NIDDK, NINDS, NIA, NIBIB and NCRR greater than 2 percent over the President's budget level.
- Increased funding for the remaining Institutes/Centers by less than 2 percent
Floor action on the bill has not been scheduled.
House - The House full Appropriations Committee is expected to mark up the bill in mid-September.
III. FIC Thirty-Fifth Anniversary Events
Fogarty International Global Health Lecture Series
FIC will launch a year -long lecture series in October that will highlight global health issues. The David E. Barmes Global Health Lecture, co-sponsored by FIC and NIDCR, which will take place October 28 at NIH, will be the first of the five lectures in this series. The schedule of lectures is as follows:
October 28 - Determinants of Global Health: Nutrition, Immunity and Infection Nevin Scrimshaw, M.D., Ph.D.
Institute Professor Emeritus at MIT and Senior Advisor, Food and Nutrition Program, United Nations University
January 28 - Smallpox: The Death and Resurrection of a Virus
D.A. Henderson, M.D., MPH, Distinguished Service Professor
Johns Hopkins University and Senior Advisor for Public Health Preparedness to the Secretary of Health and Human Services
April 14 - Global Health Priorities: Diseases, Injuries and Risk Factors
Alan Lopez, Ph.D.
Professor of Medical Statistics and Population Health and Head, School of Population Health, University of Queensland
June 12 - Title to be Announced
Gail Cassel, Ph.D.
Vice President, Scientific Affairs and
Distinguished Lilly Research Scholar for Infectious Diseases Eli Lilly and Company
Sept. 22 - The Epidemic of Depression, Suicide and Violence in Developing Societies
Arthur Kleinman, M.D.
Maude and Lillian Presley Professor of Medical Anthropology,
Professor of Psychiatry, and Chair, Department of Social Medicine
Harvard University
35th Anniversary Scientific Symposium
A scientific symposium entitled "Science for Global Health" is scheduled for May 20-21 2003 at the William H. Natcher Center on the NIH campus. The symposium aims to raise awareness of the potential of science to diminish global health disparities. Participants, who include prominent thinkers and actors in global health, will address four areas: Why Global Health Matters; Opportunities and Challenges; Collaborative Research Across Geographic Boundaries; and Impact of Research Capacity Building in Developing Countries.
IV. FIC Programs and Initiatives
XIV International AIDS Conference
FIC staff participated in several NIH-wide activities organized by the NIH Office of AIDS Research at the XIV International AIDS Conference in Barcelona Spain in July. Dr. Jeanne McDermott gave a presentation on two new FIC programs, the International Clinical, Operational and Health Services Research and Training Award for AIDS and Tuberculosis (ICOHRTA AIDS/TB) and the Global Health Research Initiative Program for New Foreign Investigators (GRIP) as part of the satellite session "NIH-Supported and Training Opportunities for International Scientists in HIV/AIDS." Drs. Bridbord, Gardner, and McDermott and Mr. Bruce Butrum led one of the six breakout groups which focused on FIC programs at a skills-building workshop "Tips on Applying for an NIH Grant: Program Opportunities and Grant Writing Skills." During the conference, FIC hosted a reception and network meeting for over 200 FIC-affiliated participants at the conference. In addition, Drs. Bridbord and McDermott participated in several meetings with other NIH representatives and Chinese officials in preparation for the upcoming Sino-U.S. Conference on Research and Training in AIDS-Related Areas to be held in Beijing on November 1-3, 2002, and Dr. Bridbord participated in a workshop, organized by a number of Indian organizations, to discuss training and capacity-building for HIV- related research and public health in India. Finally, Ms. Natalie Tomitch participated in an OAR-hosted satellite meeting with several Russian researchers and policymakers to discuss the issue of expanding U.S.-Russian collaboration in HIV/AIDS research. An outcome of the discussion was consensus to form a joint working group to formalize research collaboration in prevention technologies, vaccines, and diagnostics for HIV/AIDS and related conditions. Plans include a joint conference in Russia in 2003.
Third MIM Pan-African Malaria Conference
Plans for the 3rd International Pan African Malaria Conference, to be held in Arusha, Tanzania, are nearly complete. FIC, NIAID, NLM and NIEHS are providing significant support for the conference, along with European science funding agencies and NGOs. Over 600 participants are expected, with more than half from malaria-endemic countries. The MIM partners will support 250 of the participants from malaria-endemic countries. The conference will consider progress in key fields of research and will work to enhance malaria collaboration between control experts and researchers.
Working with Visiting Scientists on Campus
FIC convened the third consultation with junior scientists from the developing world July 29 at the Stone House. The meeting focused on the first round of applications for the GRIP the new re-entry grant, the development of an extramural mentoring program, and how to promote communications between the fellows and beyond the NIH.
World AIDS Foundation/French and American AIDS Foundation (WAF/FAAF)
The Boards of the WAF and FAAF held their annual meeting at the Lawton Chiles International House on June 28 and approved approximately 2 million dollars in grant support. Participants discussed the projected ending of WAF/FAAF in 2004, at which time the royalty stream that funds the two foundations will come to an end, and developed initial plans for a major symposium to be held in Paris in the summer of 2003. The symposium will review the impact of WAF/FAAF programs on the response to HIV/AIDS in developing countries and the development of local capacity to address the multifaceted needs of HIV-infected individuals. NIH director Zerhouni is a member of the boards of the WAF and the FAAF and Drs. Keusch and Kirschstein participated in the meeting.
Back to top ^
V. Multilateral Initiative on Malaria (MIM)
MIM Secretariat to Move to Sweden
As agreed when the MIM was launched in 1997, the MIM Secretariat rotates among sponsoring agencies every three years. The Wellcome Trust served as the first MIM Secretariat and FIC as the second. A group of voting representatives, consisting of 10 funding partners from the North and 11 African countries representing 16 research institutions, considered applications from member organizations and recently announced that they had selected Stockholm University, Karolinska Insitute and the Swedish Institute for Infectious Disease Control to serve jointly as Secretariat from 2003 to 2005. The transfer will take place shortly after the 3rd MIM Pan-African Malaria Conference in November.
MIM Review
An independent panel chaired by Enriqueta Bond, President of the Burroughs Wellcome Fund, will conduct a review of MIM from September 30-October 4. The goal of the review is to provide perspective to program leadership and to the new MIM Secretariat on the activities and coordination of the various MIM activities. The review will be a broad-based and qualitative assessment to provide an overview of how MIM is addressing the needs of the malaria research community in Africa. A summary report of the review panel's findings will be presented at the MIM conference in November. Funding for this review will come from the NIH 1% Evaluation Set-Aside Funds and from MIM partner agencies.
Disease Control Priorities in Developing Countries Project (DCPP)
In follow-up to a presentation on DCPP given by Drs. Keusch and Jamison at the meetings of NIH IC Directors and IC International Representatives respectively, DCPP staff has met with NIH leadership, including directors of eight ICs and the NIH Office of General Counsel to explain the DCPP project and enlist IC support. In addition, editorial meetings to review progress and choose chapter lead/coordinating authors for the 73-chapter book were hosted by co-editor Sir George Alleyne at the Pan American Health Organization (PAHO) on June 10-11 and July 23, and planning is continuing for a DCPP-sponsored meeting on cost-effectiveness to be held November 6-7 at the FIC, and for a Multilateral Initiative on Malaria (MIM)-DCPP workshop on the burden of malaria to be held on November 17 at the MIM Conference in Arusha, Tanzania.
Stigma and Global Health Research Program
FIC has issued a new RFA for the Stigma and Global Health Research Program, which stimulates interdisciplinary research on stigma in health and how to intervene to prevent or mitigate its effects on the health and welfare of individuals, groups, and societies worldwide. The deadline for receipt of applications for this new program is November 14.
International Consultation on Brain Disorders
FIC convened an international consultation on June 4 to consider the broad topic of brain disorders in the developing world and potential research needs and opportunities. Dr. Torsten Wiesel, Secretary General of the International Brain Research Organization and Director of the Human Frontier Science Program, co-chaired the meeting with Dr. Keusch. The meeting was called, in part, to consider recommendations from the recent Institute of Medicine (IOM) report on the topic, supported by FIC, NICHD, NIMH and NINDS. FIC and its NIH partners are developing of a new program in this area to be launched in FY 2003.
Network Meetings
FIC and NIH partners convened network meetings of grantees and trainees under the International Training and Research Program on Population and Health (June 10-11); the Ecology of Infectious Disease Program (June 12-13); International Clinical, Operational and Health Services Research Training Program (June 20-21); and the International Maternal and Child Health Research and Training Program (July 23-24). These network meetings are held in order to share information on experiences and discuss possible future collaborations.
Review of the FIRCA
In the first half of FY 03, FIC will conduct phase I of a two-phase evaluation of the FIRCA program, which was launched in FY 92. The goals of Phase I are to: 1) examine existing program data to determine its sufficiency and integrity, 2) design additional data collection instruments as needed, 3) conduct pilot tests of data collection instruments, and 4) determine if an outcome evaluation is appropriate and design that evaluation if it is. Abt Associates, which has evaluated previous FIC programs, will perform the evaluation with funding from the NIH 1% Evaluation Set-Aside Funds. FIC anticipates that Phase II of the evaluation will be conducted in the second half of FY 03 and into FY 04.
VI. Regional Activities
China
The Chinese Minister of Public Health, Dr. Zhang Wenkang signed a Memorandum of Understanding (MOU) in June with DHHS Secretary Tommy Thompson on U.S.-China cooperation in HIV/AIDS. The MOU was signed during Dr. Zhang's recent visit to Washington, at which time he met with Dr. Zerhouni, FIC, and other senior officials at NIH who are involved in collaboration with China on HIV/AIDS.
Egypt
The annual Board meeting of the U.S.-Egypt Joint Science and Technology Fund was held in Washington, D.C. in May. NIH staff reviewed 19 proposals, seven of which will be funded in this cycle. Each proposal demonstrated substantial involvement of junior scientists. The Board approved a $1 million increase in funding from each side for the next fiscal year, which began in June.
Russia
The tenth meeting of the U.S.-Russia Health Committee, co-chaired by HHS and USAID, took place in Washington, D.C. on July 31. The meeting focused on current collaboration in access to quality health care, infectious diseases, maternal and child health and cardiovascular disease. The Russian Minister of Health and his delegation also spent a day at the NIH campus for additional discussions, a visit to the Vaccine Research Center, and a FIC-hosted luncheon, with participation by representatives from NHLBI, NIAID, NIAAA, NIDA, NIMH, NICHD and OAR.
Taiwan
The American Institute in Taiwan (AIT) and the Taipei Economic and Cultural Representative's Office (TECRO) convened a meeting June 11 at NIH on cooperation in the life sciences between the U.S. and Taiwan biomedical research organizations. FIC staff and representatives of other NIH institutes and centers and their counterparts from Taiwan presented on existing areas of collaboration related to drug abuse and rehabilitation, genomic research, natural products and medicinal plants for drug development, bioinformatics training and research, clinical sciences training, asthma and epidemiology. New areas in which collaboration appears promising were discussed and responsibilities for follow-up actions assigned.
Back to top ^
VII. Activities of FIC Staff Members
Dr. Gerald Keusch took part in a periodic meeting of the Disease Control Priorities Project staff June 10-11 to discuss and refine the publication that is planned for this project. The June meeting focused on choosing chapter lead authors and discussions by the Editors on the DCPP Economic Analysis Plan.
Dr. Keusch represented NIH and the WHO ACHR at the meeting of the PAHO/Advisory Committee on Health Research June 12-14 in Washington. Topics discussed included Health in Human Development, Health Promotion and Protection, Environmental Protection and Development, Development of Health Systems and Services, and Disease Prevention and Control.
Dr. Keusch represented NIH at the WHO Advisory Committee on Health Research (ACHR) June 18-19 in Geneva. Topics for discussion included the ACHR Report on Genomics and World Health, the World Health Summit 2002, and World Health Day 2004.
Dr. Keusch gave the Segal lecture, "A New Life for Global Health," at Tufts University Medical Center June 21 in Boston.
Dr. Keusch attended a meeting of the Tropical Medicine Interest Group at The Wellcome Trust June 26 in London, England to review applications for grants in tropical medicine. Dr. Keusch is a member of the Special Advisory Group of The Wellcome Trust - Burroughs-Wellcome Fund Infectious Disease Initiative.
Dr. Keusch visited the University of Wisconsin in Madison August 14-16 to visit the University's Institute for Global Studies.
Dr. Keusch attended a meeting of the Global Alliance for Improved Nutrition (GAIN) September 5 or 6 in Geneva, Switzerland. Dr. Keusch is the scientific advisor for the GAIN Enabling Group and this meeting convened to select the first Board of Trustees.
Dr. Martin Alilio, MIM Conference Coordinator, made a conference site visit for the 3rd Pan African Malaria Conference August 26-30 in Arusha, Tanzania. He briefed the U.S. Deputy Chief of Mission and the Local Organizing Committee, among others.
Ms. Nalini Anand attended an international DNA Sampling Conference in Montreal, Canada September 5-7.
Dr. Joel Breman gave a seminar on June 12 at the FIC entitled "Polio Elimination and Eradication: A Bangladesh Odyssey" at which he recounted his experiences from January through March 2002 in Bangladesh as a consultant to the World Health Organization.
Dr. Breman gave a presentation entitled "Smallpox: The Disease" on June 15 at the Institute of Medicine, National Academy of Sciences, as part of an IOM-sponsored symposium on "Smallpox: The Scientific Basis for Vaccination Policy Options."
Dr. Breman attended an NIAID-sponsored meeting of the NIH Lyme Disease Coodinating Committee on June 18 at NIH.
Dr. Breman attended a meeting of the International Affairs Committee of the Infectious Diseases Society of America June 20-21 in San Juan, Puerto Rico, at which he gave a presentation on FIC activities and future initiatives.
Dr. Breman attended a meeting on Standardization of Monitoring and Evaluation for Malaria Control on July 15-16 in Washington, D.C. The meeting was sponsored by USAID and the Roll Back Malaria Project, WHO.
Dr. Kenneth Bridbord, Dr. Pierce Gardner and Dr. Barbara Sina attended the 4th World Congress on Tuberculosis June 3-5 in Washington. Dr. Gardner served as rapporteur for the plenary sessions on Progress in Drug Development, Vaccine Development and Diagnostics Development.
Dr. Bridbord, Dr. Alastair Clayton and Ms. Mildred Hatton took part in the WAF/FAAF Board meetings held at NIH on June 28.
Dr. Bridbord, Mr. Bruce Butrum, Dr. Pierce Gardner, Dr. Jeanne McDermott, Dr. Mark Miller and Ms. Natalie Tomitch participated in the XIV International AIDS Conference in Barcelona July 6-12. Each played a significant role in fostering FIC program interests and in establishing new partnerships with scientists, administrators and foreign grantees.
Dr. Andrea Egan attended the annual meeting of the MIM/TDR Task Force in March in Uganda to observe the review of applications for MIM-TDR research grants. MIM/TDR is currently supporting 18 research projects in Africa.
Dr. Jean-Marc Depinay participated in a meeting on Antibody Protection Against Viral Infections (Special Reference to Dengue Fever) June 3-4 at NIH.
Dr. Pierce Gardner attended the 4th World Congress on Tuberculosis June 3-5 in Washington and served as the rapporteur for the plenary sessions on Progress in Drug Development, Vaccine Development and Diagnostics Development.
Mr. George Herrfurth represented NIH at the State Department interagency meeting on cloning held on July 22 at the State Department. The United States will participate in a meeting of the UN ad hoc Committee on Cloning from September 23-27 in New York to review the merits of pursuing negotiations of a global convention to prohibit human reproductive cloning.
Mr. Herrfurth coordinated the NIH review and input into the review of the WHO Essential Medicines List (EML). The EML will be reviewed in early 2003 by the WHO Committee on Essential Medicines.
Mr. Herrfurth represented NIH at the August 15 meeting of the Biosafety Interagency Group to review the latest developments related to the anticipated entry into force of the Biosafety Protocol to the Biodiversity Convention. The Group also reviewed the results of recent negotiations associated with the UN Model Regulations on the Transport of Dangerous Goods.
Dr. Karen Hofman organized and chaired a panel session entitled "Violence and Injury: The Neglected Epidemic" at the Global Health Council 9th Annual Conference held May 31 in Washington, DC.
Dr. Hofman participated in the FIC consultation on "Brain Disorders and Cognitive Function in Low and Middle Income Countries: Developing a Research Agenda" June 4 in Bethesda.
Dr. Hofman attended a conference on Genomics and Public Policy and was a panelist and presenter in a session on the health-genomics divide June 7-8 in Toronto, Canada.
Dr. Sharon Hrynkow gave a presentation on FIC/NIH International Activities to a Department of State-sponsored group of European health and sports experts attending a multi-city program titled "Women in Sports." They visited NIH on June 7 to learn how NIH programs relate to women's health in sport and exercise.
Dr. Hrynkow gave a presentation on "NIH Opportunities - the Extramural Perspective" at the European Congress of Perinatal Medicine held in Oslo, Norway June 18-26. While in Oslo, she met with officials of the Research Council of Norway, the Ministry of Education and Research, and the National Hospital.
Dr. Hrynkow and FIC staff met with Dr. Hee-Yol Yu, Vice Minister of Science and Technology, Republic of Korea, on July 3 to discuss NIH-Korea collaboration and a proposed forum on biomedical sciences to be held later this year.
Dr. Hrynkow convened the third consultation with Visiting Fellows from developing countries and countries in transition on July 29 at the Stone House.
Dr. Hrynkow gave the keynote address "Postdocs and Sparks" at the Neuroscience Postdoc day at Northwestern University August 13 in Chicago.
Dr. Hrynkow chaired the bi-monthly meeting of the NIH IC international representatives and other U.S. agencies on July 9. Dr. Wendy Baldwin, NIH Deputy Director for Extramural Research and Director, Office of Extramural Programs spoke of the proposed NIH policy changes related to Intellectual Property Rights and foreign grantees. FIC program staff also reported on the current activities of the International Nutrition Research Subcommittee, the outcome of the first round of GRIP applications, a proposed visit of an NIH delegation to Brazil and Argentina to explore new opportunities in biomedical collaboration, and on the status of the international malaria conference to be held in November in Arusha, Tanzania.
Dr. Dean Jamison attended meetings at Harvard and Boston Universities regarding DCPP and health/development linkages May 15-16 in Boston.
Dr. Jamison gave a presentation to a meeting of the pharmacoeconomics Society May 21 in Crystal City, Virginia.
Dr. Jamison participated in a meeting of the Institute of Medicine Board on Neurosciences and Behavior regarding possible international projects June 10 in Washington.
Dr. Jamison co-chaired a meeting in Oslo, August 22-23, on the "Economics of Immunization". This meeting was sponsored by the Global Alliance for Vaccines and Immunization.
Dr. Richard Krause traveled to the Institute of Infectious Diseases in Braunschweig, Germany June 3-5 to attend the Program Planning and Steering Committee Meeting of the 15th Lancefield International Symposium on Streptococcal Diseases, which will be held in Goa, India October 6-10. While in Germany, he gave a lecture on "Staphylococcus Aureus Immunity: From Mirage to Reality" at the Max Planck Institute of Immunology in Freiburg and at the Institute of Hygiene, University of Cologne.
Dr. Krause was a member of the U.S. Delegation to the U.S.-Japan Cooperative Medical Science Program meetings from July 22-26 in Tokyo. The Program was established in 1975 to foster cooperation between the two countries on research for the benefit of the peoples of Southeast Asia.
Dr. Krause, because of his longstanding interest in medical research collaboration with scientists in India, took a leave of absence from July 26-August 4 to take a one-week course at Christ Church College, Oxford University on the history of the British Raj in India and the struggle for independence.
Dr. James Lavery and staff of the NIH Clinical Center Department of Clinical Bioethics conducted and taught a workshop on Ethical Aspects of Clinical Research June 18-21 in Seoul, Korea.
Dr. Lavery chaired the first meeting of the DHHS Working Group on "Equivalen Protections", a U.S. regulatory mechanism for approving international institutions' systems of human subjects research protections July 25 in Washington.
Dr. Ellis McKenzie participated in two workshops on the Ecology of Infectious Diseases, one held near Novosibirsk, Russia, and the other at the Lawton Chiles International House, NIIH.
Dr. McKenzie gave a talk on Mathematical Modeling of Malaria May 9 at Johns Hopkins University's Bloomberg School of Public Health in Baltimore, Maryland.
Dr. McKenzie participated in the launch conference for the 5-year Special Focus on Mathematical and Computational Epidemiology June 26 -July 2 at the Center for Discrete Mathematics and Theoretical Computer Science in Piscataway New Jersey.
Dr. McKenzie participated in conference sessions on bioterrorism modeling, at the Society for Industrial and Applied Mathematics, July 11-12 in Philadelphia, Pennsylvania.
Dr. Kathleen Michels helped organize and represented FIC at the NIH International Conference on Children Exposed to Violence: State of the Knowledge, Gaps and Research Priorities, which was intended to inform development of an RFA to be issued by NICHD and partners. The conference was held July 24-26 at NIH and Dr. Michels moderated a break-out session on war and terrorism.
Dr. Michels participated in an NIMH-sponsored conference on Stigma, Mental Illness and the Media July 29-30 at NIH. She discussed the new Stigma and Global Health RFA with participants in the hope of stimulating ideas for multidisciplinary research on the role of the media.
Dr. Mark Miller attended the Global Pertussis Initiative Roundtable Meeting, June 1-2 in Paris, France.
Dr. Miller co-organized a meeting for Antibody Protection Against Viral Infections (Special Reference to Dengue) June 3-4, 2002 at the Lawton Chiles International House at NIH.
Dr. Miller served on the scientific committee and was an instructor at the 3rd Advanced Vaccinology Course June 11-14 in Veryier du Lac, Switzerland. Topics included the multifaceted nature of vaccinology, assessing vaccines in clinical trials, and the role of preclinical vaccine research.
Dr. Miller attended the 3rd annual Global Vaccine Research Forum (GAVI), June 9-11 in Geneva, Switzerland, to discuss vaccine research and development issues, update research agendas and monitor progress.
Dr. Miller participated the Strategic Advisory Group of Experts Meeting (SAGE), June 13-14 in Geneva, Switzerland. The group discussed the progress and status of the Vaccines and Biologicals strategic plan for the upcoming years.
Dr. Miller attended the International AIDS Conference 2002 in Barcelona, Spain. The FIC Division of International Epidemiology andPopulation Studies (EPS) has been engaged in research involving the update of potential vaccines against HIV in addition to the risk of HIV transmission from unsafe injections.
Dr. Miller was a consultant to the UNAIDS/WHO Initiative for Vaccine Research Group July 22 - August 9 in Geneva, Switzerland. Participants reviewed factors related to the introduction of HIV vaccines and outlined a research agenda for introduction of vaccines related to HIV/AIDS.
Dr. Miller was a member of the WHO Product Development Group meeting for Aerosol Measles. This meeting was to advise WHO's Initiative for Vaccine Research on the studies required to safely and successfully make respiratory vaccination a tool for use in the field
Dr. Rachel Nugent represented NIH at the 4th Preparatory Committee meeting for the World Summit on Sustainable Development (WSSD) May 23-June 4 in Indonesia. The purpose of the meeting was to finalize a negotiated plan of action for sustainable development implementation and to confer with international organizations and country delegations about partnerships to carry out the plan. Dr. Nugent also represented NIH at the WSSD, which was held in Johannesburg, South Africa.
Dr. Nugent served as a co-chair of the Subcommittee on International Nutrition Research of the trans-NIH Nutrition Coordinating Committee at its second meeting on June 12. Topics included a review of a draft WHO/FAO report on Diet, Nutrition and Prevention of Chronic Diseases and trends in chronic disease incidence in developing countries.
Dr. Aron Primack attended a meeting of FIC trainees under the University of California Los Angeles International Training and Research Program in Environmental and Occupational Health. The meeting was held May 28 in Mexico City.
Dr. Primack represented FIC at the meeting of the planning committee for the 5th International Conference on the Scientific Basis of Health Services, which will be held September 20-23 in Washington, D.C.
Dr. Primack gave a talk on FIC international programs, particularly the GRIP program, at the 7th NIDA International Forum "Building International Research on Drug Abuse: Treatment Innovations," June 14 in Quebec City, Canada.
Dr. Joshua Rosenthal gave an invited talk on the Ecology of Infectious Diseases and participated in a newly formed International Working Group on Ecosystem Change and Infectious Diseases at the Conference on Health Ecosystems, June 7-10 in Washington, D.C.
Dr. Rosenthal led the first network meeting and workshop of the interagency program on the Ecology of Infectious Diseases June 12-13 at NIH.
Dr. Rosenthal participated in the Founder's Meeting of the Public Interest Intellectual Property Advocates at the offices of Venable Associates, July 3 in Washington, D.C.
Dr. Rosenthal attended the annual meeting of the American Society of Pharmacognosy in New Brunswick, July 28-29 in New Brunswick, New Jersey.
Dr. Luis Salicrup visited Argentina and Uruguay August 11-20 to explore ways in which NIH-supported researchers could continue to work effectively in the current economic crisis. In Argentina, Dr. Salicrup consulted with biomedical research centers and universities, the Argentinean Council of Science and Technology, the Ministry of Health and the U.S. Embassy; in Uruguay, he met with the Ministry of Health; the National Council for Innovation, Science and Technology; the National Directorate for Innovation, Science and Technology; and the National University and research institutions to discuss Uruguay's participation in the NIH-Uruguay Pan American Fellowship Program and other NIH programs. These consultations were the first phase of a broader DHHS-wide strategy that is being coordinated by Secretary Thompson's in response to the Argentinean and Uruguayan requests.
Dr. Salicrup attended a planning meeting August 21-22 in Brazil for the upcoming Pan American Genetics Research Workshop that will be held in Rio de Janeiro in October. The workshop is being organized by FIC, the Oswaldo Cruz Foundation and PAHO.
Dr. Barbara Sina participated in a Workshop on Laboratory Methods for Studying Placental Malaria July 30-August 2 at the Biotechnology Center of the University of Yaounde, Cameroon. The Workshop was organized by Dr. Diane Taylor, Georgetown University, who has a FIC International Maternal and Child Health Research Training program award, in collaboration with Dr. Rose Leke at the University of Yaounde.
Ms. Natalie Tomitch and staff of NIH's Office of Intramural Research visited Sofia, Bulgaria May 25-June 1 to explore the possibility of establishing a partnership between universities and research institutes in Bulgaria and the NIH Graduate Partnerships Program for the pre-doctoral training of Bulgarian graduate students. The visit also was an opportunity to inform Bulgarian biomedical scientists of NIH collaborative research and training opportunities.
Back to top ^
